DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV	MAPPED_TRAIT	MAPPED_TRAIT_URI	STUDY ACCESSION	GENOTYPING TECHNOLOGY
2019-03-27	28864454	Lacson JCA	2017-09-01	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/28864454	Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study.	Breast cancer (estrogen-receptor positive)	1,325 cases, 1,310 controls	NA	10q26.13	10	121577821	FGFR2	FGFR2			ENSG00000066468			rs2981579-T	rs2981579	0	2981579	intron_variant	0		4E-7	6.3979400086720375		1.23		Illumina [129771]	N	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	GCST007415	Exome genotyping array [Exome array]
2019-03-27	28864454	Lacson JCA	2017-09-01	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/28864454	Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Teachers Study.	Breast cancer (estrogen-receptor positive)	1,325 cases, 1,310 controls	NA	16q12.1	16	52565276	CASC16	CASC16			ENSG00000249231			rs4784227-T	rs4784227	0	4784227	intron_variant	0		7E-6	5.154901959985743		1.23		Illumina [129771]	N	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	GCST007415	Exome genotyping array [Exome array]
2018-07-17	29423119	Khan S	2017-11-28	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/29423119	Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer.	Survival in breast cancer (estrogen-receptor positive)	2,971 European ancestry individuals, 165 individuals	NA				RHOBTB2, PDLIM2							rs2314686-?	rs2314686	0	2314686	regulatory_region_variant	1		2E-8	7.698970004336019		1.89	[1.66-2.11]	Illumina [275827] (imputed)	N	event free survival time, estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_0000482, http://www.ebi.ac.uk/efo/EFO_1000649	GCST005901	Genome-wide genotyping array
2018-07-17	29423119	Khan S	2017-11-28	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/29423119	Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer.	Survival in breast cancer (estrogen-receptor positive)	2,971 European ancestry individuals, 165 individuals	NA	8p21.2	8	23578869	PDLIM2, RHOBTB2	SLC25A37 - RNU4-71P; No mapped genes; No mapped genes						rs4996307-?; rs992531-?; 2314686-?	rs4996307; rs992531; rs2314686	0		regulatory_region_variant; intergenic_variant; regulatory_region_variant		0.0693	2E-7	6.698970004336019		1.71	[1.4-2.07]	Illumina [275827] (imputed)	N	event free survival time, estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_0000482, http://www.ebi.ac.uk/efo/EFO_1000649	GCST005901	Genome-wide genotyping array
2018-07-17	29423119	Khan S	2017-11-28	Oncotarget	www.ncbi.nlm.nih.gov/pubmed/29423119	Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer.	Survival in endocrine treated breast cancer (estrogen-receptor positive)	2,629 European ancestry individuals, 122 individuals	NA	5q21.3	5	105742977	RAB9P1							rs7701292-?	rs7701292	0	7701292	intergenic_variant	1		2E-8	7.698970004336019		1.79	[1.59-1.99]	Illumina [275827] (imputed)	N	event free survival time, estrogen-receptor positive breast cancer, response to endocrine therapy	http://www.ebi.ac.uk/efo/EFO_0000482, http://www.ebi.ac.uk/efo/EFO_1000649, http://www.ebi.ac.uk/efo/EFO_0007613	GCST005900	Genome-wide genotyping array
2016-04-28	25964295	Khan S	2015-05-11	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/25964295	Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy.	Survival in endocrine treated breast cancer (estrogen-receptor positive)	352 European ancestry cases with endocrine therapy, 254 European ancestry cases without endocrine therapy, 597 European ancestry controls	3,330 European ancestry cases with endocrine therapy, 42 European ancestry cases without endocrine therapy, 1,351 European ancestry controls	19q13.41	19	51942133	ZNF613	ZNF613			ENSG00000176024			rs8113308-G	rs8113308	0	8113308	intron_variant	0	0.152	6E-7	6.221848749616356		1.69	[1.37-2.07]	Illumina [486478]	N	survival time, estrogen-receptor positive breast cancer, breast carcinoma, response to endocrine therapy	http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0007613	GCST002901	Genome-wide genotyping array
2017-03-20	28171663	Huo D	2016-09-04	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/28171663	Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.	Breast cancer (estrogen-receptor positive)	1795 African American cases, 99 African ancestry cases, 4,150 African American controls, 624 African ancestry controls	1093 African American cases, 2939 African American controls	2q35	2	217029040	intergenic							rs12998806-G	rs12998806	0	12998806	intergenic_variant	1	0.86	2E-8	7.698970004336019		1.34	[1.21-1.48]	Illumina [16147413] (imputed)	N	estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_1000649	GCST003781	Genome-wide genotyping array
2020-06-16	31904872	Chou WC	2020-01-06	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31904872	A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.	Survival in breast cancer (estrogen-receptor positive)	953 Taiwanese individuals	NA	1q24.2	1	168570139	MCF-7,T47D	XCL2 - XCL1	ENSG00000143185	ENSG00000143184		26142	6466	rs76462307-?	rs76462307	0	76462307	intergenic_variant	1		1E-6	6.0				Affymetrix [632566] (imputed)	N	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	GCST010079	Genome-wide genotyping array
2020-06-16	31904872	Chou WC	2020-01-06	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31904872	A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.	Survival in breast cancer (estrogen-receptor positive)	953 Taiwanese individuals	NA	3q13.31	3	116561041	intergenic	LSAMP, LINC00903			ENSG00000185565, ENSG00000241397			rs1401069-?	rs1401069	0	1401069	intron_variant	0		5E-7	6.301029995663981				Affymetrix [632566] (imputed)	N	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	GCST010079	Genome-wide genotyping array
2020-06-16	31904872	Chou WC	2020-01-06	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31904872	A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.	Survival in breast cancer (estrogen-receptor positive)	953 Taiwanese individuals	NA	6p12.3	6	46573494	intergenic	CYP39A1			ENSG00000146233			rs2178052-?	rs2178052	0	2178052	intron_variant	0		5E-6	5.301029995663981				Affymetrix [632566] (imputed)	N	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	GCST010079	Genome-wide genotyping array
2020-06-16	31904872	Chou WC	2020-01-06	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31904872	A Functional Variant Near XCL1 Gene Improves Breast Cancer Survival via Promoting Cancer Immunity.	Survival in breast cancer (estrogen-receptor positive)	953 Taiwanese individuals	NA	11q23.3	11	121289351	intergenic	RPS4XP12 - SC5D	ENSG00000244400	ENSG00000109929		38373	3330	rs1560409-?	rs1560409	0	1560409	intergenic_variant	1		2E-6	5.698970004336019				Affymetrix [632566] (imputed)	N	survival time	http://www.ebi.ac.uk/efo/EFO_0000714	GCST010079	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	7q21.13	7	90874752	CDK14	CDK14			ENSG00000058091			rs10953024-C	rs10953024	0	10953024	intron_variant	0	0.088	1E-6	6.0		0.49	[0.29-0.69] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	2q37.2	2	236277682	ASB18	ASB18 - IQCA1	ENSG00000182177	ENSG00000132321		13273	46465	rs1453308-A	rs1453308	0	1453308	intron_variant	1	0.198	2E-6	5.698970004336019		0.33	[0.19-0.47] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	18p11.23	18	7807950	PTPRM	PTPRM			ENSG00000173482			rs16952550-C	rs16952550	0	16952550	intron_variant	0	0.171	2E-6	5.698970004336019		0.33	[0.19-0.47] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	15q21.2	15	51261712	CYP19A1	CYP19A1, MIR4713HG			ENSG00000137869, ENSG00000259240			rs17601876-A	rs17601876	0	17601876	intron_variant	0	0.5	4E-6	5.3979400086720375		0.24	[0.14-0.34] unit increase	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	2q37.2	2	236278055	ASB18	ASB18 - IQCA1	ENSG00000182177	ENSG00000132321		13646	46092	rs1453307-G	rs1453307	0	1453307	intron_variant	1	0.1638	3E-6	5.522878745280337		0.3463	[0.2-0.49] unit increase	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	17q22	17	58163947	OR4D2	OR4D1 - OR4D2	ENSG00000141194	ENSG00000255713		4362	3035	rs16942732-T	rs16942732	0	16942732	intergenic_variant	1	0.2054	8E-6	5.096910013008056		0.2847	[0.16-0.41] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	11q24.2	11	126175935	RPUSD4	NA - RPUSD4		ENSG00000165526			26161	rs7105310-G	rs7105310	0	7105310	non_coding_transcript_exon_variant	1	0.1072	7E-6	5.154901959985743		0.3841	[0.22-0.55] unit increase	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA				LOC100506029							chr1:101579551-A	chr1:101579551	0			1	0.1747	6E-6	5.221848749616356		0.322	[0.18-0.46] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	1q42.13	1	230289344	GALNT2	GALNT2 - PGBD5	ENSG00000143641	ENSG00000177614		7222	25146	rs16851421-G	rs16851421	0	16851421	intergenic_variant	1	0.3271	8E-6	5.096910013008056		0.2489	[0.14-0.36] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	5q23.1	5	117038818	RPL35AP15							rs113883744-T	rs113883744	0	113883744	intergenic_variant	1	0.2103	8E-6	5.096910013008056		0.2971	[0.17-0.43] unit increase	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	17q22	17	58165213	LOC100419764	OR4D1 - OR4D2	ENSG00000141194	ENSG00000255713		5628	1769	rs1468574-A	rs1468574	0	1468574	intergenic_variant	1	0.2052	8E-6	5.096910013008056		0.2847	[0.16-0.41] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	7p14.3	7	34103644	BMPER	BMPER			ENSG00000164619			rs1420338-G	rs1420338	0	1420338	intron_variant	0	0.3988	7E-6	5.154901959985743		0.2432	[0.14-0.35] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	9p24.1	9	8211949	PTPRD							rs1416584-G	rs1416584	0	1416584	intergenic_variant	1	0.0787	6E-6	5.221848749616356		0.4453	[0.25-0.64] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	10p12.2	10	23061174	ARMC3	ARMC3 - MSRB2	ENSG00000165309	ENSG00000148450		22651	34405	rs3858207-C	rs3858207	0	3858207	intron_variant	1	0.4898	5E-6	5.301029995663981		0.2398	[0.14-0.34] unit decrease	Illumina [8203257] (imputed)	N	androstenedione measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007972, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004361	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone levels in resected estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	14q24.2	14	70423423	ADAM21, LOC105370555, C14orf55	ADAM21			ENSG00000139985			rs12586722-A	rs12586722	0	12586722	intron_variant	0	0.155	1E-6	6.0		0.3	[0.18-0.42] pg/mL increase	Illumina [8203257] (imputed)	N	estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007970	GCST004362	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone levels in resected estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	14q24.2	14	70452982	PLEKHD1	ADAM21			ENSG00000139985			rs8014252-G	rs8014252	0	8014252	intron_variant	0	0.1556	2E-6	5.698970004336019		0.2981	[0.18-0.42] pg/mL increase	Illumina [8203257] (imputed)	N	estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007970	GCST004362	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	19p13.12	19	14774988	EMR2, ADGRE2	ADGRE2			ENSG00000127507			rs57712673-A	rs57712673	0	57712673	intron_variant	0	0.349	1E-7	7.0		0.36	[0.23-0.49] pg/mL increase	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	7p14.2	7	36899717	ELMO1	ELMO1			ENSG00000155849			rs59964204-A	rs59964204	0	59964204	intron_variant	0	0.096	3E-7	6.522878745280337		0.45	[0.28-0.62] pg/mL decrease	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	10q23.2	10	86667452	LDB3	OPN4 - LDB3	ENSG00000122375	ENSG00000122367		604	1055	rs34346910-C	rs34346910	0	34346910	regulatory_region_variant	1	0.111	6E-7	6.221848749616356		0.49	[0.3-0.68] pg/mL increase	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	8q24.3	8	142925688	LOC100288248, CYP11B2	CYP11B2 - LY6E-DT	ENSG00000179142	ENSG00000247317		7845	56050	rs6988985-C	rs6988985	0	6988985	intergenic_variant	1	0.461	7E-7	6.154901959985743		0.25	[0.15-0.35] pg/mL increase	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma androstenedione levels in resected early stage-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	10p14	10	8346355	LOC100507143	LINC00708 - NA	ENSG00000232170			78013		rs7075481-G	rs7075481	0	7075481	intergenic_variant	1	0.1279	8E-7	6.096910013008056		0.3776	[0.23-0.53] pg/mL increase	Illumina [8203257] (imputed)	N	androstenedione measurement	http://www.ebi.ac.uk/efo/EFO_0007972	GCST004363	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	12p12.1	12	21178615	SLCO1B1	SLCO1B1			ENSG00000134538			rs4149056-C	rs4149056	0	4149056	missense_variant	0	0.136	4E-11	10.397940008672037		0.5	[0.35-0.65] pg/mL increase	Illumina [8203257] (imputed)	N	estrone conjugate measurement	http://www.ebi.ac.uk/efo/EFO_0007971	GCST004359	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	12p12.1	12	21215863	SLCO1B1	SLCO1B1			ENSG00000134538			rs2900478-A	rs2900478	0	2900478	intron_variant	0	0.14	7E-10	9.154901959985743		0.48	[0.33-0.63] pg/mL increase	Illumina [8203257] (imputed)	N	estrone conjugate measurement	http://www.ebi.ac.uk/efo/EFO_0007971	GCST004359	Genome-wide genotyping array
2021-03-25	32701512	Cairns J	2020-07-23	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	11q14.1	11	83983729	DLG2	DLG2			ENSG00000150672			rs2449598-A	rs2449598	0	2449598	intron_variant	0	0.4808	2E-10	9.698970004336019		0.4897	[0.34-0.64] unit decrease	Illumina [up to 8000000] (imputed)	N	estrogen measurement, response to aromatase inhibitor	http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477	GCST011407	Genome-wide genotyping array
2021-03-25	32701512	Cairns J	2020-07-23	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	16q21	16	64410685	CDH11							rs1437153-G	rs1437153	0	1437153	intron_variant	1	0.0618	3E-9	8.522878745280337		0.4028	[0.27-0.53] unit decrease	Illumina [up to 8000000] (imputed)	N	estrogen measurement, response to aromatase inhibitor	http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477	GCST011407	Genome-wide genotyping array
2021-03-25	32701512	Cairns J	2020-07-23	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	8p23.2	8	3217516	CSMD1	CSMD1			ENSG00000183117			rs6981827-?	rs6981827	0	6981827	intron_variant	0	NR	2E-8	7.698970004336019	(estradiol)			Illumina [up to 8000000] (imputed)	N	estrogen measurement, response to aromatase inhibitor	http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477	GCST011407	Genome-wide genotyping array
2021-03-25	32701512	Cairns J	2020-07-23	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	8p23.2	8	3217516	CSMD1	CSMD1			ENSG00000183117			rs6981827-?	rs6981827	0	6981827	intron_variant	0	NR	2E-8	7.698970004336019	(estrone)			Illumina [up to 8000000] (imputed)	N	estrogen measurement, response to aromatase inhibitor	http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477	GCST011407	Genome-wide genotyping array
2021-03-25	32701512	Cairns J	2020-07-23	JCI Insight	www.ncbi.nlm.nih.gov/pubmed/32701512	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.	Estrogen level change in anastrozole-treated breast cancer	624 individuals	NA	8p23.2	8	3217516	CSMD1	CSMD1			ENSG00000183117			rs6981827-C	rs6981827	0	6981827	intron_variant	0	0.0502	2E-8	7.698970004336019	(estrone and estradiol)	0.5978	[0.39-0.8] unit decrease	Illumina [up to 8000000] (imputed)	N	estrogen measurement, response to aromatase inhibitor	http://www.ebi.ac.uk/efo/EFO_0011007, http://purl.obolibrary.org/obo/GO_0061477	GCST011407	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	1p31.1	1	76397851	NR	ST6GALNAC3			ENSG00000184005			rs4369272-G	rs4369272	0	4369272	intron_variant	0	0.2554	5E-6	5.301029995663981		0.2719	[0.16-0.39] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	1p31.1	1	76398384	NR	ST6GALNAC3			ENSG00000184005			rs4949715-A	rs4949715	0	4949715	intron_variant	0	0.2557	5E-6	5.301029995663981		0.2716	[0.16-0.39] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	2q37.1	2	232353879	NR	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		2570	24845	rs6715187-G	rs6715187	0	6715187	intergenic_variant	1	0.1826	8E-8	7.096910013008056		0.3644	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	2q37.1	2	232353864	NR	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		2555	24860	rs6715387-A	rs6715387	0	6715387	intergenic_variant	1	0.1829	9E-8	7.045757490560675		0.3641	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	2q37.1	2	232353552	NR	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		2243	25172	rs6729965-C	rs6729965	0	6729965	intergenic_variant	1	0.183	9E-8	7.045757490560675		0.3641	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	2q37.1	2	232352849	NR	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		1540	25875	rs55738617-T	rs55738617	0	55738617	regulatory_region_variant	1	0.1812	9E-8	7.045757490560675		0.3646	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	2p21	2	42794053	NR	HAAO - FTOP1	ENSG00000162882	ENSG00000226491		1460	3172	rs1065643-G	rs1065643	0	1065643	regulatory_region_variant	1	0.09075	1E-6	6.0		0.4449	[0.27-0.62] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	5q23.2	5	126046631	NR	RPSAP37 - NA	ENSG00000241888			78546		rs10519881-G	rs10519881	0	10519881	intron_variant	1	0.3156	4E-6	5.3979400086720375		0.2607	[0.15-0.37] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	5p15.31	5	9317600	NR	SEMA5A			ENSG00000112902			rs12658330-G	rs12658330	0	12658330	intron_variant	0	0.0207	5E-6	5.301029995663981		0.902	[0.52-1.28] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	5q23.2	5	126045975	NR	RPSAP37 - NA	ENSG00000241888			77890		rs7724529-T	rs7724529	0	7724529	intron_variant	1	0.3159	5E-6	5.301029995663981		0.2597	[0.15-0.37] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	7q22.3	7	105858521	NR	ATXN7L1			ENSG00000146776			rs62482803-A	rs62482803	0	62482803	intron_variant	0	0.2132	3E-6	5.522878745280337		0.3058	[0.18-0.43] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	7q11.22	7	71534157	NR	GALNT17			ENSG00000185274			rs11769266-G	rs11769266	0	11769266	intron_variant	0	0.3817	3E-6	5.522878745280337		0.2495	[0.15-0.35] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	7q11.22	7	71534123	NR	GALNT17			ENSG00000185274			rs4557585-G	rs4557585	0	4557585	intron_variant	0	0.3817	3E-6	5.522878745280337		0.2495	[0.15-0.35] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	10p11.23	10	29652692	NR	SVIL			ENSG00000197321			rs80082057-T	rs80082057	0	80082057	intron_variant	0	0.0276	5E-7	6.301029995663981		0.7723	[0.47-1.07] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	10p11.23	10	29647954	NR	SVIL			ENSG00000197321			rs75690380-G	rs75690380	0	75690380	intron_variant	0	0.0277	6E-7	6.221848749616356		0.7692	[0.47-1.07] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	10p11.23	10	29655323	NR	SVIL			ENSG00000197321			rs78721916-T	rs78721916	0	78721916	intron_variant	0	0.0224	2E-6	5.698970004336019		0.8776	[0.52-1.23] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58669872	NR	SLC38A7			ENSG00000103042			rs12598355-C	rs12598355	0	12598355	intron_variant	0	0.1193	1E-7	7.0		0.4221	[0.27-0.58] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58673228	NR	SLC38A7			ENSG00000103042			rs11639682-A	rs11639682	0	11639682	intron_variant	0	0.1204	8E-7	6.096910013008056		0.3938	[0.24-0.55] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58678226	NR	SLC38A7			ENSG00000103042			rs2280398-T	rs2280398	0	2280398	intron_variant	0	0.1213	2E-6	5.698970004336019		0.3795	[0.23-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58698951	NR	SLC38A7 - GOT2	ENSG00000103042	ENSG00000125166		14181	8180	rs11643617-C	rs11643617	0	11643617	regulatory_region_variant	1	0.1234	2E-6	5.698970004336019		0.3767	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58677628	NR	SLC38A7			ENSG00000103042			rs2280399-A	rs2280399	0	2280399	intron_variant	0	0.1214	2E-6	5.698970004336019		0.3752	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58701769	NR	SLC38A7 - GOT2	ENSG00000103042	ENSG00000125166		16999	5362	rs73549255-A	rs73549255	0	73549255	intergenic_variant	1	0.1236	2E-6	5.698970004336019		0.3777	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58659688	NR	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		29803	5421	rs60388585-C	rs60388585	0	60388585	intergenic_variant	1	0.1454	3E-6	5.522878745280337		0.3447	[0.2-0.49] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58673724	NR	SLC38A7			ENSG00000103042			rs59234479-A	rs59234479	0	59234479	intron_variant	0	0.1178	3E-6	5.522878745280337		0.3738	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58697980	NR	SLC38A7 - GOT2	ENSG00000103042	ENSG00000125166		13210	9151	rs11647748-G	rs11647748	0	11647748	intergenic_variant	1	0.1185	3E-6	5.522878745280337		0.3743	[0.22-0.53] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	18q22.3	18	72975302	NR	NETO1-DT - NA	ENSG00000263958			93903		rs9945654-G	rs9945654	0	9945654	intergenic_variant	1	0.0124	4E-6	5.3979400086720375		2.0652	[1.2-2.93] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	18q22.3	18	72975319	NR	NETO1-DT - NA	ENSG00000263958			93920		rs9945951-A	rs9945951	0	9945951	intergenic_variant	1	0.0126	4E-6	5.3979400086720375		2.0573	[1.19-2.93] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	1p31.1	1	76398018	NR	ST6GALNAC3			ENSG00000184005			rs4342892-A	rs4342892	0	4342892	intron_variant	0	0.2555	5E-6	5.301029995663981		0.272	[0.16-0.39] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	2q37.1	2	232355544	intergenic	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		4235	23180	rs28845026-T	rs28845026	0	28845026	intergenic_variant	1	0.1987	5E-8	7.301029995663981		0.3673	[0.24-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	5q23.2	5	126041980	NR	RPSAP37 - NA	ENSG00000241888			73895		rs12518356-G	rs12518356	0	12518356	intron_variant	1	0.3123	4E-6	5.3979400086720375		0.2618	[0.15-0.37] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	7q11.22	7	71535629	NR	GALNT17			ENSG00000185274			rs6460664-C	rs6460664	0	6460664	intron_variant	0	0.3768	2E-6	5.698970004336019		0.2535	[0.15-0.36] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	8q22.1	8	97892687	NR	MATN2			ENSG00000132561			rs4489302-C	rs4489302	0	4489302	intron_variant	0	0.0143	3E-6	5.522878745280337		1.3599	[0.8-1.92] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	10p11.23	10	29653623	NR	SVIL			ENSG00000197321			rs77628230-T	rs77628230	0	77628230	intron_variant	0	0.0278	5E-7	6.301029995663981		0.7739	[0.48-1.07] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	12q23.1	12	96161387	NR	LINC02452			ENSG00000283422			rs77034926-A	rs77034926	0	77034926	non_coding_transcript_exon_variant	0	0.1805	2E-6	5.698970004336019		0.3403	[0.2-0.48] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	15q26.3	15	99507178	NR	NA - RPL7P5		ENSG00000241562			44204	rs8038589-T	rs8038589	0	8038589	intergenic_variant	1	0.0206	3E-6	5.522878745280337		0.9179	[0.54-1.3] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58662802	SLC38A7	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		32917	2307	rs11648166-G	rs11648166	0	11648166	regulatory_region_variant	1	0.1178	2E-8	7.698970004336019		0.4401	[0.29-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	18q23	18	76553300	NR	LINC00683			ENSG00000266256			rs62112924-A	rs62112924	0	62112924	intron_variant	0	0.033	2E-6	5.698970004336019		1.188	[0.7-1.67] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	19p13.2	19	8857556	NR	MUC16			ENSG00000181143			rs76164207-A	rs76164207	0	76164207	intron_variant	0	0.1655	4E-6	5.3979400086720375		0.4204	[0.24-0.6] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	20p11.23	20	20984347	NR							rs6106324-C	rs6106324	0	6106324	intergenic_variant	1	0.381	5E-6	5.301029995663981		0.2473	[0.14-0.35] unit decrease	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	2q37.1	2	232350693	intergenic	ECEL1P3			ENSG00000230122			rs883013-T	rs883013	0	883013	intron_variant	0	0.1854	6E-8	7.221848749616356		0.3644	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	2q37.1	2	232350750	intergenic	ECEL1P3			ENSG00000230122			rs4996188-A	rs4996188	0	4996188	intron_variant	0	0.1851	7E-8	7.154901959985743		0.3631	[0.23-0.49] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	2q37.1	2	232353782	intergenic	ECEL1P3 - ALPP	ENSG00000230122	ENSG00000163283		2473	24942	rs6715083-T	rs6715083	0	6715083	intergenic_variant	1	0.1824	8E-8	7.096910013008056		0.3649	[0.23-0.5] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58669712	SLC38A7	SLC38A7			ENSG00000103042			rs3784911-T	rs3784911	0	3784911	intron_variant	0	0.1191	4E-8	7.3979400086720375		0.4353	[0.28-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58661235	SLC38A7	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		31350	3874	rs60979655-T	rs60979655	0	60979655	regulatory_region_variant	1	0.1129	5E-8	7.301029995663981		0.4378	[0.28-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58670592	SLC38A7	SLC38A7			ENSG00000103042			rs16960359-A	rs16960359	0	16960359	intron_variant	0	0.1189	5E-8	7.301029995663981		0.4324	[0.28-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58668637	SLC38A7	SLC38A7			ENSG00000103042			rs76733922-C	rs76733922	0	76733922	intron_variant	0	0.1213	6E-8	7.221848749616356		0.4257	[0.27-0.58] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2019-04-29	30648747	Dudenkov TM	2019-01-16	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/30648747	Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.	Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer	634 European ancestry individuals, 40 African ancestry individuals, 13 Asian ancestry individuals	NA	16q21	16	58657060	SLC38A7	CNOT1 - SLC38A7	ENSG00000125107	ENSG00000103042		27175	8049	rs12149056-A	rs12149056	0	12149056	intergenic_variant	1	0.1162	7E-8	7.154901959985743		0.4341	[0.28-0.59] unit increase	Illumina [~ 600000] (imputed)	N	response to aromatase inhibitor	http://purl.obolibrary.org/obo/GO_0061477	GCST007664	Genome-wide genotyping array
2017-07-17	28429243	Dudenkov TM	2017-04-20	Breast Cancer Res Treat	www.ncbi.nlm.nih.gov/pubmed/28429243	SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.	Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	707 European ancestry postmenopausal cases, 52 African ancestry postmenopausal cases, 15 Asian ancestry postmenopausal cases	NA	12p12.1	12	21168436	SLCO1B1	SLCO1B1			ENSG00000134538			rs10841753-C	rs10841753	0	10841753	intron_variant	0	0.208	3E-12	11.522878745280337		0.43	[0.31-0.55] unit decrease	Illumina [8203257] (imputed)	N	estrone conjugate measurement, estrone measurement	http://www.ebi.ac.uk/efo/EFO_0007971, http://www.ebi.ac.uk/efo/EFO_0007970	GCST004360	Genome-wide genotyping array
2018-11-27	30161160	Onishi H	2018-08-30	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30161160	A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	275 East Asian ancestry individuals	72 East Asian or Asian ancestry individuals	4q34.3	4	181490427	NR							rs4861477-C	rs4861477	0	4861477	intergenic_variant	1	0.15	8E-6	5.096910013008056				Illumina [519335] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST006615	Genome-wide genotyping array
2018-11-27	30161160	Onishi H	2018-08-30	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30161160	A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study.	Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	275 East Asian ancestry individuals	72 East Asian or Asian ancestry individuals	4q34.3	4	181486725	NR							rs17198973-C	rs17198973	0	17198973	intergenic_variant	1	0.35	6E-6	5.221848749616356				Illumina [519335] (imputed)	N	response to tamoxifen	http://www.ebi.ac.uk/efo/EFO_0009391	GCST006615	Genome-wide genotyping array
2015-12-07	25890600	Guo Q	2015-04-18	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/25890600	Identification of novel genetic markers of breast cancer survival.	Breast cancer (survival)	23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases		14q24.1	14	67599772	NR	PIGH			ENSG00000100564			rs7149859-?	rs7149859	0	7149859	intron_variant	0		7E-7	6.154901959985743	(ER +ve)	1.22	[1.13-1.33]	Affymetrix, Illumina [9000000] (imputed)	N	survival time, estrogen-receptor positive breast cancer	http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_1000649	GCST002861	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	7q22.3	7	106631389	NR	NA - CCDC71L		ENSG00000253276			22971	rs375468501-?	rs375468501	0	375468501	intron_variant	1	NR	3E-6	5.522878745280337		1.3377686	[1.18-1.51]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	16q22.1	16	67082698	NR	CBFB			ENSG00000067955			rs140538758-?	rs140538758	0	140538758	intron_variant	0	NR	6E-7	6.221848749616356		1.5044404	[1.28-1.77]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	9q21.12	9	70158086	NR	MAMDC2-AS1, MAMDC2-AS1, MAMDC2, MAMDC2			ENSG00000277409, ENSG00000204706, ENSG00000278608, ENSG00000165072			rs55686336-?	rs55686336	0	55686336	intron_variant	0	NR	3E-6	5.522878745280337		1.5113994	[1.27-1.80]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	22q12.1	22	27918624	NR	PITPNB			ENSG00000180957			rs62235635-?	rs62235635	0	62235635	intron_variant	0	NR	1E-6	6.0		1.6262683	[1.34-1.98]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	22q12.1	22	28365160	NR	TTC28			ENSG00000100154			rs62237617-?	rs62237617	0	62237617	intron_variant	0	NR	2E-6	5.698970004336019		1.6840287	[1.36-2.09]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	17p13.3	17	919380	NR	NXN, NXN, NXN			ENSG00000167693, ENSG00000280563, ENSG00000281300			rs118021774-?	rs118021774	0	118021774	intron_variant	0	NR	4E-6	5.3979400086720375		1.8284526	[1.42-2.36]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA				NR							chr5:1227088-?	chr5:1227088	0			1	NR	2E-6	5.698970004336019		1.1522056	[1.09-1.22]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	21q22.3	21	45497121	NR	SLC19A1, COL18A1			ENSG00000173638, ENSG00000182871			rs73370840-?	rs73370840	0	73370840	intron_variant	0	NR	9E-7	6.045757490560675		1.1648589	[1.10-1.24]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	14q12	14	24401845	NR	NYNRIN			ENSG00000205978			rs7160316-?	rs7160316	0	7160316	intron_variant	0	NR	2E-6	5.698970004336019		0.61414945	[0.50-0.75]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	4q35.1	4	185141891	NR	LINC02436 - SLC25A4	ENSG00000250754	ENSG00000151729		26391	1375	rs79116769-?	rs79116769	0	79116769	intergenic_variant	1	NR	6E-7	6.221848749616356		0.7772595	[0.70-0.86]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	17p13.3	17	3000998	NR	RAP1GAP2			ENSG00000132359			rs12938141-?	rs12938141	0	12938141	intron_variant	0	NR	5E-7	6.301029995663981		0.77756035	[0.70-0.86]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	6p25.2	6	2634705	NR	LINC02521			ENSG00000228718			rs6938753-?	rs6938753	0	6938753	non_coding_transcript_exon_variant	0	NR	1E-6	6.0		0.8705196	[0.82-0.92]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA				NR							chr7:41400313-?	chr7:41400313	0			1	NR	3E-6	5.522878745280337		0.8813266	[0.84-0.93]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	7q11.22	7	70935714	NR							rs4717568-?	rs4717568	0	4717568	regulatory_region_variant	1	NR	1E-7	7.0		0.88204163	[0.84-0.92]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	9q33.1	9	116142133	NR	NA - PAPPA		ENSG00000182752			11658	rs204517-?	rs204517	0	204517	intergenic_variant	1	NR	3E-6	5.522878745280337		0.8883291	[0.85-0.93]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	10p15.2	10	3554755	NR	LINC02669 - NA	ENSG00000233321			51840		rs11251942-?	rs11251942	0	11251942	intron_variant	1	NR	5E-7	6.301029995663981		1.1186024	[1.07-1.17]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	10p14	10	7272478	NR	SFMBT2			ENSG00000198879			rs7082321-?	rs7082321	0	7082321	intron_variant	0	NR	1E-6	6.0		1.1424168	[1.08-1.21]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	5p13.3	5	32017440	NR	PDZD2			ENSG00000133401			rs11289719-?	rs11289719	0	11289719	intron_variant	0	NR	3E-6	5.522878745280337		1.1424453	[1.08-1.21]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	15q25.1	15	80763524	NR	ABHD17C - CEMIP	ENSG00000136379	ENSG00000103888		7903	15819	rs149479659-?	rs149479659	0	149479659	intergenic_variant	1	NR	2E-6	5.698970004336019		1.1531807	[1.09-1.22]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA				NR							chr12:27965596-?	chr12:27965596	0			1	NR	4E-6	5.3979400086720375		1.1574948	[1.09-1.23]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	4q28.3	4	136496076	NR							rs12505589-?	rs12505589	0	12505589	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.1673031	[1.09-1.25]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
2019-03-28	30787463	Escala-Garcia M	2019-02-21	Br J Cancer	www.ncbi.nlm.nih.gov/pubmed/30787463	Genome-wide association study of germline variants and breast cancer-specific mortality.	Breast cancer specific mortality in estrogen receptor positive breast cancer	4,116 European ancestry cases, 60,055 European ancestry controls	NA	6q27	6	167818409	NR	LINC01558 - AFDN-DT	ENSG00000146521	ENSG00000198221		21537	3694	rs587150-?	rs587150	0	587150	intron_variant	1	NR	1E-6	6.0		1.2127603	[1.12-1.31]	Affymetrix, Illumina [~ 10400000] (imputed)	N	mortality	http://www.ebi.ac.uk/efo/EFO_0004352	GCST007475	Genome-wide genotyping array
